Work

A Phase 1 Study of LY3410738, a First-in-Class Covalent Inhibitor of Mutant IDH in Advanced Myeloid Malignancies (Trial in Progress)

Year: 2020

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2020-134307

Authors: Eytan M. Stein, Marina Konopleva, Raymond Gilmour, Anna M Szpurka, Elizabeth Hill, Renee Ward, Hagop M. Kantarjian, Courtney D. Dinardo

Institutions: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, Loxo Oncology at Lilly (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3095729908

Cites:

Cited by: 16

Related to: 10